GTCH - Huge News Out! SAN DIEGO, Oct. 27, 2020
Post# of 35216
![](/assets/46931549/no_avatar_available_thumb.jpg)
SAN DIEGO, Oct. 27, 2020 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”), announced that GBT Tokenize Corp (“GBT/Tokenize”), the Company’s joint venture, has concluded qTerm device's features, adding two features.
qTerm, a human vitals device, powered by AI, is aimed to measure human vitals with a touch of a finger. The device also received its Trademark allowance notice and will present it on the product/package as required by the United State Patent Office (“USPTO”).
In its first release, the qTerm device is targeted to measure body temperature, blood oxygen level and heart rate – all with a simple touch of the finger. An advanced circuitry and sensory systems will be implemented in order to enable these features. These three vitals measurements can provide important health factors for early viral infection detection. The device can be easily attached to the back of a smartphone or used as a standalone apparatus. If the reading is of concern, the user will receive a timely visual alert. qTerm smart phone app will keep a history for the user's records and provide numerical and statistical data about the user's body temperature.
qTerm’s mobile app is planned to be powered by AI, anonymously and securely collecting the user data, building potentially a worldwide ‘thermal map’ to alert about potential health risks proximities. The device's initial features have been determined and GBT/Tokenize is seeking to produce its initial prototypes.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)